Bronchial thermoplasty for severe asthma safe, effective, durable at 5 years

Patients with severe asthma experienced decreased exacerbations, hospitalizations, ED visits and corticosteroid exposure 5 years after treatment with bronchial thermoplasty, researchers reported.
Five-year safety and efficacy data from the Post-FDA Approval Clinical Trial Evaluating Bronchial Thermoplasty in Severe Persistent Asthma Study (PAS2) were published in Chest.
“With approval of bronchial thermoplasty, and any therapy, there are always questions about long-term efficacy and safety — this prompted the PAS2 trial,” Geoffrey Chupp, MD, professor of pulmonary medicine and

Patients with severe asthma experienced decreased exacerbations, hospitalizations, ED visits and corticosteroid exposure 5 years after treatment with bronchial thermoplasty, researchers reported.
Five-year safety and efficacy data from the Post-FDA Approval Clinical Trial Evaluating Bronchial Thermoplasty in Severe Persistent Asthma Study (PAS2) were published in Chest.
“With approval of bronchial thermoplasty, and any therapy, there are always questions about long-term efficacy and safety — this prompted the PAS2 trial,” Geoffrey Chupp, MD, professor of pulmonary medicine and